Lung Cancer Diagnosis and Treatment
Lung Cancer Diagnosis and Treatment is a research topic within Pulmonary and Respiratory Medicine. Science Explorer counts 62k research works in it since 1950. 15.5% of them reached the world's top 10% most cited for their field and year.
This cluster of papers focuses on the diagnosis and treatment of lung cancer, including topics such as CT screening, radiotherapy, chemotherapy, tumor staging, adjuvant therapy, positron emission tomography, stereotactic body radiation therapy, non-small cell lung cancer, and pulmonary nodules.
- Lung Cancer
- CT Screening
- Radiotherapy
- Chemotherapy
- Tumor Staging
- Adjuvant Therapy
- Positron Emission Tomography
- Stereotactic Body Radiation Therapy
- Non-Small Cell Lung Cancer
- Pulmonary Nodules
- Research works
- 62k fractional, since 1950
- In the world top 10%
- 9.6k per year above
- Top-10% rate
- 15.5% share of its works in the world top 10%
- Growth, 2013–17 → 2018–22
- +34% the tick is no change
This ranks research output and citation impact. It says nothing about the quality of diagnosis, treatment or care.
Which countries lead Lung Cancer Diagnosis and Treatment research?
By volume, China and the United States publish the most (3.6k and 2.9k works in 2022–2025).
By volume, 2022–2025
- 1 China 3.6k works
- 2 United States 2.9k works
- 3 Japan 1.1k works
- 4 India 938 works
- 5 United Kingdom 614 works
- 6 Germany 483 works
- 7 Italy 451 works
- 8 South Korea 410 works
- 9 France 336 works
- 10 Spain 295 works
How concentrated that is
The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.
Shares of the rows listed above, not of the whole node.
Which institutions lead Lung Cancer Diagnosis and Treatment research?
By volume in 2022–2025, Chinese Academy of Medical Sciences & Peking Union Medical College publishes the most Lung Cancer Diagnosis and Treatment research, followed by The University of Texas MD Anderson Cancer Center and Sichuan University.
By volume, 2022–2025
- 1 Chinese Academy of Medical Sciences & Peking Union Medical CollegeChina 110 works
- 2 The University of Texas MD Anderson Cancer CenterUnited States 76 works
- 3 Sichuan UniversityChina 68 works
- 4 Memorial Sloan Kettering Cancer CenterUnited States 65 works
- 5 West China Hospital of Sichuan UniversityChina 50 works
- 6 Sun Yat-sen UniversityChina 49 works
- 7 Shanghai Jiao Tong UniversityChina 49 works
- 8 Shanghai Chest HospitalChina 47 works
- 9 Peking UniversityChina 46 works
- 10 Shandong First Medical UniversityChina 46 works
Who are the leading researchers in Lung Cancer Diagnosis and Treatment?
The most-cited researchers publishing on Lung Cancer Diagnosis and Treatment include Lesley Stewart.
- 1 Lesley Stewart United Kingdom 20k citations
Ranked by citations received across their whole record, among researchers with at least three works on this topic.
Where is Lung Cancer Diagnosis and Treatment research done?
The largest centres of Lung Cancer Diagnosis and Treatment research in 2022–2025 are Beijing (China), Shanghai (China), Guangzhou (China) and Tokyo (Japan). Among places with at least 20 works in it, it is an unusually large share of all research in Plainview, Kashiwa and Maebashi.
Largest cities, 2022–2025
Where it is the local speciality
- PlainviewUS · 32.9 works31×
- KashiwaJP · 31.8 works25×
- MaebashiJP · 20.5 works11×
Location quotient: how much more of its research is in Lung Cancer Diagnosis and Treatment than the world average.
Where is the best place to study Lung Cancer Diagnosis and Treatment?
Among universities, judged by research, Chinese Academy of Medical Sciences & Peking Union Medical College, Ulsan College and Shandong First Medical University score highest, combining excellence, specialisation, size, growth and international reach. Research strength is one signal when choosing where to study; it does not measure teaching.
One dot per university in the table below. The upper left is the interesting corner: small places doing unusually strong work.
| # | University | Score | Top 10% | Specialisation | Works | Growth |
|---|---|---|---|---|---|---|
| 1 | Chinese Academy of Medical Sciences & Peking Union Medical CollegeChina | 66.6 | 16.4% | 8.3× | 110 | +130.1% |
| 2 | Ulsan CollegeSouth Korea | 57.0 | 23.5% | 9.3× | 12 | +101.7% |
| 3 | Shandong First Medical UniversityChina | 56.0 | 16.2% | 13.2× | 46 | +7.6% |
| 4 | Shanghai Medical College of Fudan UniversityChina | 55.0 | 21.8% | 10.1× | 11 | +80.3% |
| 5 | Guangzhou Medical UniversityChina | 54.6 | 16.3% | 9.3× | 34 | +43.5% |
| 6 | University of UlsanSouth Korea | 54.0 | 24.7% | 7.0× | 17 | +88.0% |
| 7 | Shanghai Jiao Tong UniversityChina | 52.7 | 21.9% | 1.6× | 49 | +217.4% |
| 8 | University of GroningenNetherlands | 51.5 | 34.8% | 1.9× | 12 | +122.4% |
| 9 | Sichuan UniversityChina | 51.0 | 17.7% | 3.0× | 68 | +145.6% |
| 10 | Juntendo UniversityJapan | 49.7 | 9.2% | 14.3× | 29 | +44.1% |
Universities only. Score blends excellence (30%), specialisation (25%), size (20%), growth (15%) and international reach (10%), 2015–2022; growth compares 2010–14 with 2015–19.
Is Lung Cancer Diagnosis and Treatment research growing?
Output in 2018–2022 was 34% higher than in 2013–2017, peaking in 2025. The fastest-growing topics are Lung Cancer Diagnosis and Treatment.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Which topics inside it are moving
Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.